KalVista PharmaceuticalsKALV
那斯達克 · USD
26.95
+0.01
(+0.04%)
收盤 06/04 04:00 (UTC+8)
06/04 04:00 (UTC+8)
KalVista PharmaceuticalsKALV
26.95
+0.01
(+0.04%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- 0.01
- 0.41
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 40,863 | 1,426 | - | - | - | - | - | - | - | - |
營業成本 | 3,090 | 590 | - | - | - | - | - | - | - | - |
營業毛利 | 37,773 | 836 | - | - | - | - | - | - | - | - |
營業費用 | 61,215 | 59,845 | 55,030 | - | - | - | 48,455 | 33,151 | 29,746 | 29,093 |
研發費用 | 12,420 | 15,162 | 15,891 | 12,593 | 16,611 | 26,614 | 25,248 | 22,523 | 19,089 | 19,307 |
推銷及管理費用 | 48,795 | 44,683 | 39,139 | 30,346 | 29,200 | 17,601 | 23,207 | 10,628 | 10,657 | 9,786 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -23,442 | -59,009 | -55,030 | -42,939 | -45,811 | -44,215 | -48,455 | -33,151 | -29,746 | -29,093 |
其他收入及費用 | - | 4,592 | 4,892 | 1,520 | 3,544 | 3,772 | 3,806 | 4,123 | 2,096 | 3,776 |
利息費用 | 5,586 | 3,522 | 2,943 | 2,842 | - | - | - | - | - | - |
稅前純益 | -23,487 | -57,939 | -53,081 | -44,261 | -42,267 | -40,443 | -44,649 | -29,028 | -27,650 | -25,317 |
所得稅 | - | 2,157 | -855 | 4,247 | - | - | - | - | - | - |
稅後純益 | -23,487 | -60,096 | -52,226 | -48,508 | -42,267 | -40,443 | -44,649 | -29,028 | -27,650 | -25,317 |
基本每股稅後盈餘(元) | -0.43 | -1.12 | -0.99 | -0.92 | -0.91 | -0.87 | - | -0.84 | -0.80 | -0.74 |
稀釋每股稅後盈餘(元) | -0.43 | -1.12 | -0.99 | -0.92 | -0.91 | -0.87 | -1.07 | -0.83 | -0.80 | -0.74 |
基本平均股數(千股) | 54583.00 | 53497.00 | 53046.00 | 52638.00 | 46695.00 | 46232.00 | - | 34723.00 | 34565.00 | 34414.00 |
稀釋平均股數(千股) | 54583.00 | 53497.00 | 53046.00 | 52638.00 | 46695.00 | 46232.00 | - | 34723.00 | 34565.00 | 34414.00 |
還原基本每股稅後盈餘(元) | -0.43 | -1.12 | -0.99 | -0.92 | -0.91 | -0.87 | - | -0.84 | -0.80 | -0.74 |
還原稀釋每股稅後盈餘(元) | -0.43 | -1.12 | -0.99 | -0.92 | -0.91 | -0.87 | -1.07 | -0.83 | -0.80 | -0.74 |
還原基本平均股數(千股) | 54,583 | 53,497 | 53,046 | 52,638 | 46,695 | 46,232 | - | 34,723 | 34,565 | 34,414 |
還原稀釋平均股數(千股) | 54,583 | 53,497 | 53,046 | 52,638 | 46,695 | 46,232 | - | 34,723 | 34,565 | 34,414 |
EBITDA(千元) | -17,546 | -54,172 | -49,874 | -41,189 | -42,035 | -40,214 | -44,426 | -28,816 | -27,432 | -25,062 |